• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Huntington Bancshares Incorporated filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    3/31/25 4:06:47 PM ET
    $HBAN
    Major Banks
    Finance
    Get the next $HBAN alert in real time by email
    hban-20250331
    0000049196false00000491962025-03-312025-03-310000049196us-gaap:SeriesHPreferredStockMember2025-03-312025-03-310000049196hban:SeriesIPreferredStockMember2025-03-312025-03-310000049196hban:SeriesJPreferredStockMember2025-03-312025-03-310000049196us-gaap:CommonStockMember2025-03-312025-03-31

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     ______________________________________________________________________________________________________________________________
    FORM 8-K
     _______________________________________________________________________________________________________________________________
    CURRENT REPORT
    Pursuant to Section 13 OR 15(d)
    of The Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported) March 31, 2025
     ______________________________________________________________________________________________________________________________
    huntingtonlogo.jpg
    Huntington Bancshares Incorporated
    (Exact name of registrant as specified in its charter)
     _______________________________________________________________________________________________________________________________
    Maryland1-3407331-0724920
    (State or other jurisdiction of
    incorporation or organization)
    (Commission
    File Number)
    (I.R.S. Employer
    Identification No.)
    Registrant's address: 41 South High Street, Columbus, Ohio 43287
    Registrant’s telephone number, including area code: (614) 480-2265
    Not Applicable
    (Former name or former address, if changed since last report.)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     _______________________________________________________________________________________________________________________________
    Securities registered pursuant to Section 12(b) of the Act:
    Title of classTrading
    Symbol(s)
    Name of exchange on which registered
    Depositary Shares (each representing a 1/40th interest in a share of 4.500% Series H Non-Cumulative, perpetual preferred stock)HBANPNASDAQ
    Depositary Shares (each representing a 1/1000th interest in a share of 5.70% Series I Non-Cumulative, perpetual preferred stock)HBANMNASDAQ
    Depositary Shares (each representing a 1/40th interest in a share of 6.875% Series J Non-Cumulative, perpetual preferred stock)HBANLNASDAQ
    Common Stock—Par Value $0.01 per ShareHBANNASDAQ
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§24012b-2).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 8.01 Other Events.
    Series I Non-Cumulative Perpetual Preferred Stock
    On March 31, 2025, Huntington announced that the Board of Directors declared and set aside a quarterly cash dividend on Huntington's 5.70% Series I Non-Cumulative Perpetual Preferred Stock (Nasdaq: HBANM) of $356.25 per share (equivalent to $0.35625 per depositary share) payable June 2, 2025, to shareholders of record on May 15, 2025. A copy of the press release is attached as Exhibit 99.1 hereto.
    Item 9.01 Financial Statements and Exhibits.
        (d) Exhibits.
    Exhibit 99.1 – News release of Huntington Bancshares Incorporated, dated March 31, 2025.
    EXHIBIT INDEX
    Exhibit No.Description
    Exhibit 99.1
    News release of Huntington Bancshares Incorporated, dated March 31, 2025
    Exhibit 104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.




    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
    HUNTINGTON BANCSHARES INCORPORATED
    Date:March 31, 2025By:
    /s/ Marcy C. Hingst
    Marcy C. Hingst
    General Counsel


    Get the next $HBAN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HBAN

    DatePrice TargetRatingAnalyst
    5/21/2025$20.00Buy
    Jefferies
    5/15/2025$20.00Buy
    TD Cowen
    4/24/2025$17.50Hold → Buy
    Deutsche Bank
    3/7/2025$18.00Neutral → Outperform
    Robert W. Baird
    12/4/2024$18.50 → $20.00Overweight
    Analyst
    7/26/2024$15.00Outperform → Neutral
    Robert W. Baird
    6/14/2024$13.50 → $11.50Neutral → Underweight
    Piper Sandler
    5/28/2024$16.00 → $18.00Neutral → Overweight
    JP Morgan
    More analyst ratings